logo

HLP

Hongli·NASDAQ
--
--(--)
--
--(--)
5.75 / 10
Netural

HLP's fundamental status is moderated with a balanced health score of 5.8/10. Positive aspects include a strong profit-to-EBIT ratio (100.0%) and a low long-term debt to working capital ratio (0.0389), both contributing to financial stability. However, the net cash flow from operating activities as a percentage of total liabilities is negative (-0.0224), signaling potential liquidity pressure. Year-over-year revenue growth is 37.714%, indicating operational expansion but not yet translating into robust cash generation. Overall, the fundamentals suggest selective optimism with caution on cash flow management.

Fundamental(5.75)SentimentTechnical

Analysis Checks(2/5)

Total operating revenue (YoY growth rate %)
Value37.71
Score0/3
Weight-8.04%
1M Return-0.45%
Total profit / EBIT (%)
Value100.00
Score2/3
Weight63.27%
1M Return2.97%
Net cash flow from operating activities / Total liabilities (%)
Value-0.02
Score0/3
Weight-12.00%
1M Return-0.69%
Long-term debt to working capital ratio (%)
Value0.04
Score2/3
Weight64.22%
1M Return2.91%
Operating revenue (YoY growth rate %)
Value37.71
Score0/3
Weight-7.45%
1M Return-0.41%
Is HLP undervalued or overvalued?
  • HLP scores 5.75/10 on fundamentals and holds a Fair valuation at present. Backed by its 1.82% ROE, 6.04% net margin, 74.84 P/E ratio, 1.36 P/B ratio, and 133.33% earnings growth, these metrics solidify its Netural investment rating.